Evidence map›Paper›PMID 37745801›Full record

ArticleFrontiers in pain research (Lausanne, Switzerland)2023

Prospective study of the effect of auricular percutaneous electrical nerve field stimulation on quality of life in children with pain related disorders of gut-brain interaction.

Ashish Chogle, Kaajal Visnagra, Jamie Janchoi, Tammy Tran, Rachel Davis, Nicole Callas, Elisa Ornelas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pain research (Lausanne, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Evidence-based review and frontiers of migraine therapy.Neurogastroenterology and motility · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ashish ChogleDivision of Pediatric Gastroenterology, Hepatology and Nutrition, CHOC Children's, Orange, CA, United States.
Kaajal VisnagraDepartment of Pediatrics, University of California Irvine, Orange, CA, United States.
Jamie JanchoiDivision of Pediatric Gastroenterology, Hepatology and Nutrition, CHOC Children's, Orange, CA, United States.
Tammy TranDivision of Pediatric Gastroenterology, Hepatology and Nutrition, CHOC Children's, Orange, CA, United States.
Rachel DavisResearch Institute, CHOC Children's, Orange, CA, United States.
Nicole CallasDivision of Pediatric Gastroenterology, Hepatology and Nutrition, CHOC Children's, Orange, CA, United States.
Elisa OrnelasDivision of Pediatric Gastroenterology, Hepatology and Nutrition, CHOC Children's, Orange, CA, United States.
Children's Hospital of Orange County · USUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Disorders of the Gut-Brain Interaction (DGBIs) account for 50% of pediatric gastrointestinal (GI) consultations. Children with DGBIs have worse quality of life (QoL) than those with organic GI disorders such as inflammatory bowel disease and gastroesophageal reflux disease. Pediatric DGBIs patients, especially those with chronic abdominal pain (AP), have impaired QoL and increased psychological distress in the form of anxiety and depression. Percutaneous Electrical Nerve Field Stimulation (PENFS) therapy has been shown to be effective in improving symptoms and functioning in children with DGBIs. The treatment's impact on these patients' QoL is unknown. Methods: This prospective study evaluated changes in QoL, gastrointestinal symptoms, functional disability, somatization, global health, anxiety, and depression in patients aged 11-18 years who received PENFS therapy (IB-stim, NeurAxis, Versailles, IN) for treatment of pain related DGBIs, once a week for four consecutive weeks. Results: This study included 31 patients with an average age of 15.7 years (SD = 2); 80.6% were female. After PENFS therapy, patients reported significant reductions in abdominal pain, nausea severity, functional disability, somatization, and anxiety from baseline to week 4 ( Conclusion: Our research demonstrates that PENFS significantly enhances the QoL of children suffering from pain-related DGBIs, in addition to improvement in GI symptoms, daily functioning, somatization, global health, and psychological comorbidities. These findings demonstrate the effectiveness of PENFS and its potential to alleviate the suffering of countless children.

Indexed as

auriculardisorder of gut brain interactionfunctional abdominal pain disordergastrointestinal disorderirritable bowel syndromepercutaneous electrical nerve field stimulationquality of life

Identifiers

PMID37745801
PMCPMC10515210
OpenAlexW4386547102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.